Notice of Intent for Monoclonal Antibodies and Plasmids Services for Influenza and Other Diseases
SAM.GOV Due: May 13, 2025 at 02:00 PM UTC
In-Active Special Notice Source Url

Summary

The National Institute of Allergy and Infectious Diseases (NIAID) is issuing a Notice of Intent to negotiate a sole source contract with Genscript USA, Inc. for the provision of monoclonal antibodies and plasmid services. This contract is aimed at supporting the NIAID Laboratory of Immunogenetics in its ongoing research to develop new vaccine candidates against influenza and other diseases. The work involves custom gene to antibody services, including the preparation of plasmid heavy and light chains, which are critical for the continuity of a master project that has already utilized Genscript's services. This opportunity is particularly suited for contractors with expertise in immunology, molecular biology, and custom antibody production, who can demonstrate their capability to provide similar services.
Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
541380
Set Aside
None
Place of Performance
Piscataway , New Jersey 08854
Point of Contact
Full Name Email Phone Type
Leah Hinson [email protected] primary
Attachments
  • 2_2260387_NOI.pdf